Effect of Diaphragm and Lubricant Gel Provision on Human Papillomavirus Infection Among Women Provided With Condoms
- 1 November 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 112 (5) , 990-997
- https://doi.org/10.1097/aog.0b013e318189a8a4
Abstract
To estimate the effect of providing women with a latex diaphragm, lubricant gel, and male condoms (intervention) compared with condoms alone (control) on human papillomavirus (HPV) incidence and clearance. Participants were 2,040 human immunodeficiency virus (HIV)-negative Zimbabwean women enrolled in a randomized trial estimating the effect of the intervention on HIV acquisition. Clinicians collected cervical samples for HPV testing at baseline, 12 months, and exit. L1 consensus polymerase chain reaction primers were used to determine HPV presence and type. We found no differences in the following outcomes: HPV prevalence at the time of the first postenrollment HPV test (intention-to-treat analysis, relative risk [RR] 1.02, 95% confidence interval [CI] 0.90-1.16); HPV incidence at 12 months among women HPV-negative at baseline (RR 0.95, 95% CI 0.80-1.14); and HPV clearance at 12 months among women HPV-positive at baseline (RR 0.80, 95% CI 0.61-1.05). Clearance of HPV type 58 was lower in the intervention group at 12 months (RR 0.67, 95% CI 0.48-0.92), but not at exit (RR 0.93, 95% CI 0.75-1.16); clearance of HPV type 18 was lower in the intervention group at exit (RR 0.55, 95% CI 0.33-0.89), but not at 12 months (RR 0.55, 95% CI 0.29-1.05). Women reporting diaphragm/gel use at 100% of prior sex acts had a lower likelihood of having one or more new HPV types detected at 12 months (RR 0.75, 95% CI 0.58-0.96) and exit (RR 0.77, 95% CI 0.59-0.99). Among women receiving risk reduction counseling and condoms in an HIV prevention program, diaphragm plus lubricant gel provision did not affect HPV incidence or clearance. ClinicalTrials.gov, www.clinicaltrials.gov, NCT00121459 I.Keywords
This publication has 14 references indexed in Scilit:
- WorldVaccine, 2007
- Human papillomavirus and cervical cancerThe Lancet, 2007
- HPV Vaccination — More Answers, More QuestionsNew England Journal of Medicine, 2007
- Condom Use and the Risk of Genital Human Papillomavirus Infection in Young WomenNew England Journal of Medicine, 2006
- Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: A randomized clinical trialInternational Journal of Cancer, 2003
- Hormonal and Barrier Methods of Contraception, Oncogenic Human Papillomaviruses, and Cervical Squamous Intraepithelial Lesion DevelopmentJournal of Women's Health & Gender-Based Medicine, 2001
- Contraceptive and Reproductive Risks for Cervical Dysplasia in Southwestern Hispanic and Non-Hispanic White WomenInternational Journal of Epidemiology, 1994
- Human papillomavirus, Herpes simplex virus and other potential risk factors for cervical cancer in a high-risk area (Greenland) and a low-risk area (Denmark) – a second lookBritish Journal of Cancer, 1993
- Barrier methods of contraception and the risk of cervical neoplasiaContraception, 1989
- Neoplasia and dysplasia of the cervix uteri and contraception: a possible protective effect of the diaphragmBritish Journal of Cancer, 1978